Serveur d'exploration Tocilizumab - Curation (Istex)

Index « Pays » - entrée « Russie »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Royaume-Uni < Russie < République populaire de Chine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000323 (2013) P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie]Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature
000379 (2013) E. Alexeeva [Russie] ; R. Denisova [Russie] ; S. Valiyeva [Russie] ; T. Bzarova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie]THU0302 Safety and efficacy of tocilizumab therapy in children with systemic onset of juvenile idiopathic arthritis
000387 (2013) R. Denisova ; E. Alekseeva [Russie] ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. FetisovaSAT0445 Survival of Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience
000397 (2013) S. Rodionovskaya [Russie] ; I. Nikishina [Russie]AB0700 Successful experience with tocilizumab in two patients with macrophage activation syndrome associated with juvenile idiopathic arthritis
000406 (2013) E. Alekseeva [Russie] ; R. Denisova ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. FetisovaSAT0459 Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience
000414 (2013) E. Denisova [Russie] ; L. Katargina [Russie] ; A. Starikova [Russie] ; N. Lubimova [Russie]THU0304 Efficacy of biologic therapies for pediatric rheumatic diseases associated uveitis
000415 (2013) A. S. Avdeeva [Russie] ; E. N. Alexandrova [Russie] ; A. V. Smirnov [Russie] ; A. A. Novikov [Russie] ; M. V. Cherkasova [Russie] ; E. Y. Panasyuk [Russie] ; E. L. Nasonov [Russie]AB0299 Association of basal level antibodies to modified citrullinated vimentin (anti-mcv) with joint destruction in rheumatoid arthritis (ra) patients during the tocilizumab (tcz) therapy
000418 (2013) E. V. Udachkina [Russie] ; D. S. Novikova [Russie] ; T. V. Popkova [Russie] ; A. S. Avdeeva [Russie] ; A. A. Novikov [Russie] ; E. N. Alexandrova [Russie] ; A. V. Volkov [Russie] ; E. L. Nasonov [Russie]AB0306 Tocilizumab therapy resulted in significantly increased heart rate variability and improved lipid profile in patients with rheumatoid arthritis
000423 (2013) E. Pogozheva ; V. Amirdzhanova ; S. Makarov [Russie]FRI0184 Postoperative complications in rheumatoid arthritis patients receiving biologic and nonbiologic disease-modifying antirheumatic drugs
000442 (2013) Y. Muraviev ; M. Podryadnova [Russie] ; E. Nasonov [Russie]AB0588 Experience of tocilizumab using for resistant adult-onset still’s disease
000450 (2013) T. Popkova [Russie] ; D. Novikova [Russie] ; E. Udachkina [Russie] ; E. Panasuk [Russie] ; A. Avdeeva [Russie] ; E. Alexandrova [Russie] ; A. Novikov [Russie] ; A. Volkov [Russie] ; E. Nasonov [Russie]AB0578 Tocilizumab influence on the serum lipid profiles and rapid progression of intima media-thickness in patients with rheumatoid arthritis
000473 (2013) E. Nasonov ; E. Panasyuk ; E. Shikina [Russie] ; T. Plaksina ; A. Dmitrieva ; L. Troegubova [Russie]AB0525 Local open-label multicenter study to evaluate the quality of life in patients with moderate to severe active rheumatoid arthritis and an inadequate response to DMARDS when adding tocilizumab
000475 (2013) E. Panasyuk [Russie] ; E. Nasonov [Russie]AB0310 Ra remission rates with tocilizumab therapy (lornet study: multicentre open-label, phase iv study of the quality of the life patient with severe/moderate ra with adding of tocilizumab to disease-modifying antirheumatic drugs therapy)
000496 (2013) S. Valiyeva [Russie] ; E. Alexeeva [Russie] ; T. Bzarova [Russie] ; R. Denisova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie]THU0303 The efficacy and safety of ibandronic acid for intravenous administration for treatment of severe systemic osteoporosis in patients with juvenile arthritis
000528 (2013) I. Guseva ; N. Soroka [Russie] ; A. Devyataykina ; G. Lukina ; E. Aleksandrova ; A. Novikov ; S. Glukhova ; D. Trofimov [Russie] ; E. Nasonov [Russie]AB0538 TNFAIP3 RS675520 variant may predict response to rituximab treatment in rheumatoid arthritis
000585 (2013) A. Alexeeva [Russie] ; Y. Mouraviev [Russie] ; E. Nasonov [Russie]AB0341 Experience of tocilizumab usage in chronic renal insufficiency stipulated by aa-amyloidosis due to rheumatoid arthritis complication
000597 (2013) M. Dubko [Russie] ; O. Kalashnikova [Russie] ; M. Kostik [Russie] ; L. Snegireva [Russie]AB0554 Abatacept (ORENCIA): Experience of practical application
000603 (2013) A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie]AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA)
000617 (2013) E. V. Tchetina ; K. H. Kuzikyants ; A. Y. Devyataikina ; G. V. Lukina ; E. L. Nasonov [Russie]AB0529 Rituximab therapy monitoring by mtor, autophagy-related ULK1, caspase 3, CDK-inhibitor P21, TNF alpha, and osteoclast-specific cathepsin K and gelatinase MMP-9 gene expression in the peripheral blood of rheumatoid arthritis patients
000620 (2013) E. Pogozheva ; V. Amirdzhanova ; S. Makarov [Russie]AB0311 Postoperative complications in rheumatoid arthritis patients receiving rituximab and conventional disease-modifying antirheumatic drugs (dmards)
000641 (2013) E. Alekseeva [Russie] ; T. Bzarova ; A. Fetisova ; S. Valieva ; K. Isayeva ; R. Denisova ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie]SAT0457 Efficacy and Safety of Etanercept in Combination with Methotrexate in the Patients with Early and Late Juvenile Idiopathic Arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPays.i -k "Russie" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPays.i  \
                -Sk "Russie" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Russie
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021